Another possible explanation for that change to the behavior of FGF19/FGFR4 is provided by Heinzle et al., who suggested that the tumor-suppressive function probably depends on the lineage-specific expression of β-klotho, which belongs to a protein family known for its role in anticancer processes [76]. This evidence concerns the gene FGFR4 and neoplasm.